| Meta-analyses involving cross-over trials: methodological issues DR Elbourne, DG Altman, JPT Higgins, F Curtin, HV Worthington, A Vail International journal of epidemiology 31 (1), 140-149, 2002 | 1753 | 2002 |
| Clinical experience with diffusion-weighted MR in patients with acute stroke. KO Lövblad, HJ Laubach, AE Baird, F Curtin, G Schlaug, RR Edelman, ... American Journal of Neuroradiology 19 (6), 1061-1066, 1998 | 767 | 1998 |
| Multiple correlations and Bonferroni’s correction F Curtin, P Schulz Biological psychiatry 44 (8), 775-777, 1998 | 763 | 1998 |
| Meta‐analysis combining parallel and cross‐over clinical trials. I: Continuous outcomes F Curtin, DG Altman, D Elbourne Statistics in medicine 21 (15), 2131-2144, 2002 | 200 | 2002 |
| 4-Oxalocrotonate tautomerase, an enzyme composed of 62 amino acid residues per monomer. LH Chen, GL Kenyon, F Curtin, S Harayama, ME Bembenek, G Hajipour, ... Journal of Biological Chemistry 267 (25), 17716-17721, 1992 | 172 | 1992 |
| Prevalence of anal incontinence and other anorectal symptoms in women DL Faltin, MR Sangalli, F Curtin, A Morabia, A Weil International Urogynecology Journal 12, 117-121, 2001 | 128 | 2001 |
| Meta‐analysis combining parallel and cross‐over clinical trials. III: The issue of carry‐over F Curtin, D Elbourne, DG Altman Statistics in medicine 21 (15), 2161-2173, 2002 | 110 | 2002 |
| Meta‐analysis combining parallel and cross‐over clinical trials. II: Binary outcomes F Curtin, D Elbourne, DG Altman Statistics in medicine 21 (15), 2145-2159, 2002 | 110 | 2002 |
| Validation of self-reported smoking status by simultaneous measurement of carbon monoxide and salivary thiocyanate A Morabia, MS Bernstein, F Curtin, M Berode Preventive medicine 32 (1), 82-88, 2001 | 106 | 2001 |
| Association between beta‐blockers, other antihypertensive drugs and psoriasis: population‐based case–control study YB Brauchli, SS Jick, F Curtin, CR Meier British journal of dermatology 158 (6), 1299-1307, 2008 | 100 | 2008 |
| The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis SB Patten, G Francis, LM Metz, M Lopez-Bresnahan, P Chang, F Curtin Multiple Sclerosis Journal 11 (2), 175-181, 2005 | 99 | 2005 |
| The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity M Garcia-Montojo, M Dominguez-Mozo, A Arias-Leal, A Garcia-Martinez, ... PloS one 8 (1), e53623, 2013 | 95 | 2013 |
| GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis—associated endogenous retrovirus: a first-in-humans randomized clinical study F Curtin, AB Lang, H Perron, M Laumonier, V Vidal, HC Porchet, ... Clinical therapeutics 34 (12), 2268-2278, 2012 | 93 | 2012 |
| Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein F Curtin, H Perron, A Kromminga, H Porchet, AB Lang MAbs 7 (1), 265-275, 2015 | 90 | 2015 |
| Meta-analyses involving cross-over trials: methodological issues MR Stedman, F Curtin, DR Elbourne, AS Kesselheim, MA Brookhart International journal of epidemiology 40 (6), 1732-1734, 2011 | 89 | 2011 |
| Body mass index compared to dual-energy x-ray absorptiometry: evidence for a spectrum bias F Curtin, A Morabia, C Pichard, DO Slosman Journal of clinical epidemiology 50 (7), 837-843, 1997 | 88 | 1997 |
| MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: relevance of GNbAC1 in multiple sclerosis treatment A Madeira, I Burgelin, H Perron, F Curtin, AB Lang, R Faucard Journal of neuroimmunology 291, 29-38, 2016 | 86 | 2016 |
| Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study YB Brauchli, SS Jick, F Curtin, CR Meier Journal of the American Academy of Dermatology 58 (3), 421-429, 2008 | 86 | 2008 |
| A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple … T Derfuss, F Curtin, C Guebelin, C Bridel, M Rasenack, A Matthey, ... Multiple Sclerosis Journal 21 (7), 885-893, 2015 | 84 | 2015 |
| Assessing the benefit: risk ratio of a drug-randomized and naturalistic evidence F Curtin, P Schulz Dialogues in clinical neuroscience 13 (2), 183-190, 2011 | 80 | 2011 |
